Compass Therapeutics Earnings
NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Compass Therapeutics earnings summary
In its most recent report on Nov 9, 2026 (Sep/2026), CMPX posted EPS of $-0.15 versus the $-0.12 consensus estimate, a negative surprise of 25.0%. Compass Therapeutics beat the consensus EPS estimate in 1 of the last 2 quarters, with a median surprise of +4.2%. Across the last 16 reports, CMPX shares moved an average of 8.9% (in either direction) in the first trading session after results, rising 12 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
CMPX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 9, 2026 | $-0.12 | $-0.15 | -25.0% | -11.1% |
| Nov 4, 2026 | $-0.12 | $-0.08 | +33.3% | +2.0% |
| Aug 6, 2026 | — | $-0.13 | — | +4.7% |
| May 5, 2026 | — | $-0.10 | — | +1.6% |
| Jan 6, 2026 | — | $-0.08 | — | +6.5% |
| Nov 5, 2025 | — | $-0.08 | — | +14.2% |
| Aug 11, 2025 | — | $-0.14 | — | +1.7% |
| May 8, 2025 | — | $-0.12 | — | +15.4% |
| Jan 8, 2025 | — | $-0.10 | — | +46.9% |
| Nov 12, 2024 | — | $-0.08 | — | +8.0% |
| Aug 12, 2024 | — | $-0.10 | — | +8.6% |
| May 13, 2024 | — | $-0.08 | — | -8.1% |
| Mar 21, 2024 | — | $-0.10 | — | -7.0% |
| Nov 9, 2023 | — | $-0.08 | — | +2.6% |
| Aug 3, 2023 | — | $-0.09 | — | +3.2% |
| May 4, 2023 | — | $-0.06 | — | -1.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.